Upgrade to SI Premium - Free Trial

Orchestra BioMed (OBIO)

3.99 +0.13 (3.37%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26 *Est.)

Latest Headlines

Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Hochman David P June 2, 2026 4:29 PM - SEC Filing Form 4 Orchestra BioMed Holding For: Jun 01 Filed by: Sherman Darren June 2, 2026 4:28 PM - SEC Filing Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 2, 2026 4:05 PM - StreetInsider Form 144 Orchestra BioMed Holding Filed by: Sherman Darren June 1, 2026 4:17 PM - SEC Filing Form 4 Orchestra BioMed Holding For: May 28 Filed by: Taylor Andrew Lawrence May 29, 2026 4:17 PM - SEC Filing Form 4 Orchestra BioMed Holding For: May 28 Filed by: Sherman Darren May 29, 2026 4:16 PM - SEC Filing Form 4 Orchestra BioMed Holding For: May 18 Filed by: Aryeh Jason May 20, 2026 8:00 AM - SEC Filing Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference May 19, 2026 8:30 AM - Globe NewsWire Orchestra BioMed Inc. (OBIO) PT Lowered to $10 at B.Riley May 19, 2026 8:22 AM - StreetInsider Form 4 Orchestra BioMed Holding For: May 15 Filed by: Aryeh Jason May 19, 2026 8:00 AM - SEC Filing Form 4 Orchestra BioMed Holding For: May 15 Filed by: Hochman David P May 19, 2026 8:00 AM - SEC Filing Form 4 Orchestra BioMed Holding For: May 14 Filed by: Fain Eric S May 18, 2026 8:00 AM - SEC Filing Orchestra BioMed Inc. (OBIO) PT Raised to $13 at Barclays May 13, 2026 4:22 AM - StreetInsider Orchestra BioMed (OBIO) Misses Q1 EPS by 33c May 12, 2026 5:47 PM - StreetInsider Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates May 12, 2026 4:18 PM - Globe NewsWire Form 10-Q Orchestra BioMed Holding For: Mar 31 May 12, 2026 4:08 PM - SEC Filing Orchestra BioMed targets BACKBEAT trial completion by Q3 2026 May 12, 2026 8:30 AM - StreetInsider Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 May 12, 2026 8:30 AM - Globe NewsWire Orchestra BioMed receives $20 million from Medtronic under financing pact May 6, 2026 8:03 AM - StreetInsider Orchestra BioMed receives $15 million from Ligand under financing agreement May 6, 2026 8:01 AM - StreetInsider Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement May 6, 2026 8:01 AM - Globe NewsWire Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement May 6, 2026 8:00 AM - Globe NewsWire FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy April 30, 2026 9:00 AM - StreetInsider Form SCHEDULE 13D/A Orchestra BioMed Holding Filed by: RTW INVESTMENTS, LP April 29, 2026 5:38 PM - SEC Filing Form 4 Orchestra BioMed Holding For: Apr 27 Filed by: RTW INVESTMENTS, LP April 29, 2026 5:37 PM - SEC Filing Form ARS Orchestra BioMed Holding For: Dec 31 April 29, 2026 4:36 PM - SEC Filing Form DEFA14A Orchestra BioMed Holding April 29, 2026 4:34 PM - SEC Filing Form DEF 14A Orchestra BioMed Holding For: Jun 23 April 29, 2026 4:31 PM - SEC Filing Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 April 23, 2026 12:00 PM - StreetInsider Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Sherman Darren March 27, 2026 4:32 PM - SEC Filing Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Aiello Joshua March 27, 2026 4:32 PM - SEC Filing Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Hochman David P March 27, 2026 4:31 PM - SEC Filing Orchestra BioMed Inc. (OBIO) PT Lowered to $9 at Jefferies March 26, 2026 10:56 AM - StreetInsider Form 4 Orchestra BioMed Holding For: Mar 13 Filed by: Hochman David P March 16, 2026 4:55 PM - SEC Filing BTIG Reiterates Neutral Rating on Orchestra BioMed Inc. (OBIO) March 13, 2026 6:12 AM - StreetInsider Chardan Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO): "warrants a new look by investors" March 12, 2026 3:17 PM - StreetInsider Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update March 12, 2026 8:17 AM - Globe NewsWire Form 10-K Orchestra BioMed Holding For: Dec 31 March 12, 2026 8:04 AM - SEC Filing Full Article List